Prognostic Factors in Colorectal Mucinous and Signet-Ring Cell Carcinomas

The histological subtypes of colorectal cancer play a decisive role in patient prognosis, treatment response and risk stratification. Mucinous adenocarcinoma, characterised by abundant extracellular mucin comprising more than 50% of tumour volume, and signet-ring cell carcinoma, defined by intracellular mucin displacing the nucleus, both exhibit aggressive clinical features compared with conventional adenocarcinoma. Patients with these subtypes often present with advanced T stage, lymph node involvement and a higher incidence of peritoneal metastasis. Molecular profiling has revealed that mucinous tumours frequently show overexpression of mucin genes such as MUC2 and MUC5AC, as well as alterations in KRAS, BRAF and PI3K/Akt pathways, whereas signet-ring cell carcinomas display distinct mutation patterns and reduced activity in canonical pathways such as WNT/β-catenin. Key prognostic factors include histological subtype, tumour stage, lymphovascular and perineural invasion, nodal burden, extracellular mucin content, and markers of tumour microenvironment immunity. Emerging biomarkers such as gene expression signatures, measures of spatial heterogeneity and composite indices integrating nodal ratios have refined risk stratification. Recognition of these features informs personalised management strategies, from surgical planning to adjuvant therapies and surveillance protocols.

Research from Nature Portfolio

Recent studies have used single-cell RNA sequencing to elucidate fundamental differences between mucinous and conventional adenocarcinoma cells, revealing that mucinous tumours express goblet cell markers (for example REG4, SPINK4 and MUC2) under the regulation of transcription factors such as TFF3 and RPS4X. These insights have clarified the cellular hierarchy that underpins the mucinous phenotype and highlighted potential prognostic signatures. Another large registry analysis compared the impact of radiotherapy across histological subtypes, showing that signet-ring cell carcinoma exhibits the poorest overall survival yet derives significant benefit from adjuvant radiotherapy in rectal primary sites, whereas mucinous adenocarcinoma demonstrates a neutral response. These findings underscore the necessity of tailoring therapeutic modalities to histopathological subtype and tumour location.

Prognostic Factors in Colorectal Mucinous and Signet-Ring Cell Carcinomas publication trend

The graph below shows the total number of articles in prognostic factors in colorectal mucinous and signet-ring cell carcinomas across all publications each year (not limited to Nature Index journals).

Technical terms

Mucinous adenocarcinoma: A colorectal cancer subtype characterised by abundant extracellular mucin representing more than half of the tumour volume.

Signet-ring cell carcinoma: A rare colorectal subtype where intracellular mucin displaces the nucleus, often associated with aggressive behaviour.

Tumour microenvironment: The cellular milieu surrounding cancer cells, including stromal and immune components that influence tumour growth.

Single-cell RNA sequencing: A technique to profile gene expression at the individual cell level, revealing cellular heterogeneity.

Spatial transcriptomics: A method combining gene expression analysis with tissue localisation to map cellular interactions within tumours.

Log odds of negative lymph node/T stage ratio (LONT): A statistical measure relating the number of unaffected lymph nodes to tumour stage for prognostic staging.

Recursive partitioning analysis (RPA): A statistical method that builds decision trees to stratify patients based on prognostic factors.

References

1. Integrating single‐cell and spatial analysis reveals MUC1‐mediated cellular crosstalk in mucinous colorectal adenocarcinoma. Clinical and Translational Medicine (2024).
2. Recursive partitioning staging system based on the log odds of the negative lymph node/T stage ratio in colon mucinous adenocarcinoma. Frontiers in Immunology (2024).
3. Single-cell profiling reveals differences between human classical adenocarcinoma and mucinous adenocarcinoma. Communications Biology (2023).
4. Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome. Cancers (2023).
5. The prognostic ability of radiotherapy of different colorectal cancer histological subtypes and tumor sites. Scientific Reports (2023).
6. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Communications (2019).
7. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. British Journal of Cancer (2019).